HCPCS Level II
J9025
Injection, azacitidine, 1 mg
Codes near J9025
These sit next to J9025 in the CMS Level II file. All J codes
- J9020Injection, asparaginase, not otherwise specified, 10, 000 units
- J9021Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022Injection, atezolizumab, 10 mg
- J9023Injection, avelumab, 10 mg
- J9024Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9026Injection, tarlatamab-dlle, 1 mg
- J9027Injection, clofarabine, 1 mg
- J9028Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- J9029Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
- J9030Bcg live intravesical instillation, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00143-9606-01 | Azacitidine | Hikma Pharmaceuticals USA Inc. | 100 |
| 00781-3491-94 | Azacitidine | Sandoz Inc. | 100 |
| 16714-0927-01 | Azacitidine | Northstar RxLLC | 100 |
| 16729-0306-10 | Azacitidine | Accord Healthcare Inc | 100 |
| 43598-0143-62 | Azacitidine | Dr. Reddy's Laboratories Inc. | 100 |
| 43598-0305-62 | Azacitidine | Dr. Reddy's Laboratories Inc. | 100 |
| 43598-0465-62 | Azacitidine | Dr. Reddy's Laboratories Inc. | 100 |
| 55150-0393-01 | Azacitidine | Eugia US LLC | 100 |
| 59572-0102-01 | Vidaza | Celgene Corporation | 100 |
| 60505-6271-01 | Azacitidine | Apotex Corp | 100 |
| 63323-0771-39 | Azacitidine | FreseniUS Kabi USA, LLC | 100 |
| 68001-0313-56 | Azacitidine | BluePoint Laboratories | 100 |
| 68001-0527-54 | Azacitidine | BluePoint Laboratories | 100 |
| 68001-0620-54 | Azacitidine | BluePoint Laboratories | 100 |
| 70121-1237-01 | Azacitidine | Amneal Pharmaceuticals, LLC | 100 |
| 71288-0115-30 | Azacitidine | Meitheal Pharmaceuticals Inc. | 100 |
| 71288-0153-95 | Azacitidine | Meitheal Pharmaceuticals Inc. | 100 |
| 72485-0201-01 | Azacitidine | Armas Pharmaceuticals Inc. | 100 |
| 72572-0020-01 | Azacitidine | Civica, Inc. | 100 |
| 75907-0225-11 | Azacitidine | Dr. Reddy's Laboratories Inc. | 100 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.